Oct 28, 2021
Immutep Receives Positive EMA Scientific Advice for Further Clinical Development of Efti in MBC Including Phase III
Oct 27, 2021
Immutep Quarterly Activities Report
Sep 30, 2021
Immutep to present Phase II TACTI-002 data at SITC 2021
Sep 28, 2021
Immutep Receives A$3.4 million R&D Tax Incentive from French Government
Immutep to Present at Healthcare Investor Conferences
